Press Release ENHERTU® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy 4 April 2025
Press Release XP Investors Have Opportunity to Join XP Inc. Fraud Investigation with the Schall Law Firm 4 April 2025
Press Release NSSC Investors Have Opportunity to Join Napco Security Technologies, Inc. Fraud Investigation with the Schall Law Firm 4 April 2025
Press Release QUBT INVESTOR ALERT: Kirby McInerney LLP Notifies Quantum Computing Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit 4 April 2025
Press Release RKLB INVESTOR ALERT: Kirby McInerney LLP Notifies Rocket Lab USA, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit 4 April 2025
Press Release Is Altus Power’s $5 Per Share Sale Price Fair? Johnson Fistel Investigates Deal Terms 3 April 2025
Press Release Helmerich & Payne, Inc. Announces Fiscal Second Quarter 2025 Conference Call and Webcast 3 April 2025
